State Drug Administration: Continue to deepen the whole process of supervision and reform, the whole chain to promote the high-quality development of the cosmetics industry

The Zhitong Finance App learned that on December 29, the State Drug Administration held a symposium on cosmetics supervision in Shijiazhuang to summarize the results of the 2025 regulatory work, analyze the current situation, and study key work ideas for 2026. The conference emphasized that 2026 is the beginning of the “15th Five-Year Plan”. It is necessary to thoroughly implement the spirit of the 20th National Congress and the 20th Plenary Session of the Party, focus on the center and focus on key points in accordance with the unified deployment of the State Drug Administration, continue to deepen the whole process of supervision and reform, establish a firm safety bottom line in all aspects, and promote the high-quality development of the cosmetics industry throughout the entire chain.

The original text is as follows:

The State Drug Administration held a symposium on cosmetics supervision

On December 29, the State Drug Administration held a symposium on cosmetics supervision in Shijiazhuang to summarize the results of the 2025 supervision work, analyze the current situation, and study key work ideas for 2026. Xu Jinghe, member of the party group and deputy director of the State Drug Administration, attended the meeting and delivered a speech.

The conference emphasized that 2026 is the beginning of the “15th Five-Year Plan”. It is necessary to thoroughly implement the spirit of the 20th National Congress and the 20th Plenary Session of the Party, focus on the center and focus on key points in accordance with the unified deployment of the State Drug Administration, continue to deepen the whole process of supervision and reform, establish a firm safety bottom line in all aspects, and promote the high-quality development of the cosmetics industry throughout the entire chain. Representatives from relevant departments, departments and units directly under the State Drug Administration, and some provincial (municipal) Drug Administration attended the meeting.

While in Shijiazhuang, Xu Jinghe visited the Hebei Pharmaceutical and Medical Device Inspection Research Institute, the Provincial Medical Device Technology Evaluation Center, and the Provincial Drug Administration Society for field research.

This article was selected from the official website of the “State Drug Administration”. Zhitong Finance Editor: Feng Qiuyi.